Borlamed

This examination is based on a modern technique of preparing a cytological specimen. The Polish Gynaecological Society recommends liquid-based cytology as a screening method for cervical cancer - it can detect early premalignant and neoplastic lesions.

Molecular testing (Real-Time PCR) characterized by high sensitivity and specificity, detecting the genetic material (DNA) of parasites: Dientamoeba fragilis, Blastocystis hominis.

Molecular test (Real-Time PCR) with high sensitivity and specificity, detecting genetic material (DNA) of parasites: Dientamoeba fragilis, Blastocystis hominis.

Tests for the presence of antibodies related to Lyme disease in both IgG and IgM classes. IgG/IgM antibodies can indicate whether Lyme disease is an active infection or completely rule out its presence in the body.

To determine the antigenic specificity of antibodies in the case of a positive or borderline ELISA test result.

The CINtec Plus test complements liquid-based cytology (LBC). It reveals concerning changes where routine cytological testing may not have provided sufficient information.

To determine the antigenic specificity of antibodies in the case of a positive or borderline ELISA test result.

Identification of HPV Genetic Material in the Patient's Body and Determination of the Type of Virus Identified.

Testing for the Presence of IgG and IgM Antibodies Against Borrelia burgdorferi, the Bacterium that Causes Lyme Disease

UROGENITAL 6 + UROGENITAL 7 + Bacterial Vaginosis + Candida 7 Test Package. This package includes an analysis for viruses, bacteria, and yeast that cause infections in the intimate areas.

Testing for IgG and IgM Antibodies Against Borrelia burgdorferi, the Bacterium Responsible for Lyme Disease

The package includes diagnostics for intimate infections covering 13 pathogens. Sexually transmitted diseases, formerly known as venereal diseases, are a group of infectious diseases transmitted through sexual contact.

The package covers an analysis for viruses, bacteria, and yeasts that are responsible for intimate infections.

Ureaplasma parvum and Ureaplasma urealyticum are pathogens responsible for a variety of persistent urinary tract infections. If left untreated, they can lead to inflammatory conditions, infertility, premature births, and even miscarriages.

The test aims to detect the presence of Mycoplasma hominis and Mycoplasma genitalium DNA in the tested material, providing diagnostics for sexually transmitted infections that enable the identification of potential co-infections and the selection of appropriate therapy.

Whooping Cough (Pertussis) is an acute infectious disease caused by the Gram-negative bacterium Bordetella pertussis. Whooping cough caused by B. parapertussis manifests with symptoms similar to those of the disease caused by B. pertussis, but it is generally less severe.

A urogenital panel is a diagnostic test used to detect the presence of specific pathogens responsible for urogenital infections. These infections can affect the urinary and genital tracts and are often sexually transmitted.

Bacterial Vaginosis (Gardnerella vaginalis, Atopobium vaginae, Lactobacillus spp., Bacteroides fragilis, Megasphaera type 1, Bacterial vaginosis-associated bacteria 2, Mobiluncus spp.)

Identification of Bacteria Causing Upper Respiratory Tract Infections.

The test aims to identify pathogens that may cause vesicular lesions/ulcers on the external genital organs.

Identification of microdeletions in the AZF region of the Y chromosome: AZFa (sY84, sY86); AZFb (sY127, sY134); AZFc (sY254, sY255). The presence of microdeletions in the AZF region of the Y chromosome causes dysfunction of proteins responsible for proper sperm production and may be a contributing factor to male infertility.

Identification of mutations in the patient's genetic material that predispose to thrombosis. The test includes identification of mutations in the Factor V (F5) gene, the Prothrombin (F2) gene, and the MTHFR gene polymorphism.

Identification of mutations predisposing to thrombosis in the patient's genetic material. The test includes the identification of mutations in the Factor V gene (F5), mutations in the Prothrombin gene (F2), and polymorphisms in the MTHFR gene.

Identification of mutations predisposing to thrombosis in the patient's genetic material. The test includes identification of mutations in the Factor V (F5) gene, mutations in the Prothrombin (F2) gene, and polymorphisms in the MTHFR gene.

Identification of MTHFR Gene Polymorphism in the Patient's Genetic Material

Identification of mutations in the Prothrombin (F2) gene in the patient's genetic material.

The HPV and CINtec Plus test enables the detection of neoplastic changes at the cellular stage, which are in the very early stages of development. This allows for the localization of cells where the normal cycle has been disrupted due to infection with high-risk human papillomavirus (HPV).

The HPV and CINtec Plus test enables the detection of neoplastic changes at the cellular stage, which are in the very early stages of development. This allows for the localization of cells where the normal cycle has been disrupted due to infection by high-risk human papillomavirus (HPV).

Identification of mutations in the Factor V (F5) gene in the patient's genetic material, commonly known as the Leiden V mutation.

Test Package Consisting of: CINtec PLUS p16/Ki67, Liquid-Based Cytology (LBC), HPV14.

Test Package Consisting of: CINtec PLUS p16/Ki67 – A test performed to deepen the diagnosis of precancerous changes and cervical cancer, Liquid-Based Cytology (LBC): A more modern and precise cytological examination technique, HPV14: Identification of 14 HPV genotypes (Human Papilloma Virus).

Molecular Testing (Real-Time PCR) is a highly sensitive and specific method that detects the genetic material (DNA) of the most commonly found human parasites, including.

The test involves analyzing stool for the presence of Cryptosporidium parvum DNA.

Molecular Testing (Real-Time PCR): A highly sensitive and specific method that detects the genetic material (DNA) of the most commonly found human parasites, including.

Molecular testing (Real-Time PCR) characterized by high sensitivity and specificity, detecting the genetic material (DNA) of 3 species of flukes: Blood fluke (Schistosoma haematobium), Liver fluke (Fasciola hepatica), Opisthorchis viverrini.

Molecular Testing (Real-Time PCR): A highly sensitive and specific method that detects the genetic material (DNA) of the most commonly found human parasites.

Parasites Package 4 - (testing for the presence of Giardia lamblia DNA and antigen in stool).

Molecular Testing (Real-Time PCR): This test is characterized by high sensitivity and specificity, detecting the genetic material (DNA) of the most commonly found human parasites.

Molecular testing (Real-Time PCR) characterized by high sensitivity and specificity, detecting the genetic material (DNA) of the most commonly found parasites in humans.

Molecular testing (Real-Time PCR) characterized by high sensitivity and specificity, detecting the genetic material (DNA) of the following parasites: Entamoeba histolytica, Entamoeba dispar.

Molecular testing (Real-Time PCR) characterized by high sensitivity and specificity, detecting the genetic material (DNA) of parasites.

Molecular Test (Real-Time PCR) characterized by high sensitivity and specificity, detecting the genetic material (DNA) of the following parasites: Human pinworm (Enterobius vermicularis), Hookworm (Ancylostoma spp.), and American hookworm (Necator americanus).

A molecular test (Real-Time PCR) characterized by high sensitivity and specificity, detecting the genetic material (DNA) of three fluke species: Blood fluke (Schistosoma haematobium), Liver fluke (Fasciola hepatica), and Opisthorchis viverrini.

Molecular testing (Real-Time PCR) characterized by high sensitivity and specificity, detecting the genetic material (DNA) of the most commonly found parasites in humans.

Simultaneous detection and genotyping of 28 different high- and low-risk HPV genotypes associated with the development of cervical cancer.

The set includes 4 test packages: Parasites Package 3 - (testing for the presence of species: Tapeworm, Whipworm, Roundworm, Dientamoeba fragilis, Blastocystis hominis, Giardia lamblia, Entamoeba histolytica), Parasites Package 4 – Flukes (testing for the presence of species: Blood Fluke, Liver Fluke, Opisthorchis viverrini), Parasites Package 5 – Nematodes (testing for the presence of species: Human Pinworm, Hookworm/Ancylostoma ceylanicum), Parasites - Cryptosporidium parvum.

Molecular testing (Real-Time PCR) characterized by high sensitivity and specificity, detecting the genetic material (DNA) of the most commonly found parasites in humans.

Thin-layer cytology (LBC) combined with HPV testing is the best method for detecting precancerous changes and cervical cancer. The additional qualitative test covering 14 high-risk HPV genotypes detects the most common high-risk types.

Molecular testing (Real-Time PCR) characterized by high sensitivity and specificity, detecting the genetic material (DNA) of parasites.

Testing using the Real-Time PCR method for the diagnosis of fungal infections; specifically targeting the presence of fungi from the Candida genus.

The test involves analyzing the material for the presence and genotyping of 14 high-risk HPV types. This test is particularly recommended for the prevention of cervical cancer in women.

The causes of the presence of blood in the stool can vary, including stomach or duodenal ulcer disease, inflammatory bowel diseases, diverticulosis of the intestines, bleeding polyps, hemorrhoids, Crohn's disease, bacterial infections, bleeding from the gums or nose, benign and malignant tumors, and colorectal cancer.